References
- Weinberger M M, Bronsky E A. Evaluation of oral bronchodilator therapy in asthmatic children. J. Pediatr 1974; 84: 421
- Mitenko P A, Ogilvie R I. Rational intravenous doses of theophylline. N Engl J Med 1973; 289: 600
- Jacobs M H, Senior R M, Kessler G. Clinical experience with theophylline: Relationships between dosage, serum concentration, and toxicity. J AM Med Assoc 1976; 235: 1983
- Tinkelman D G, Vanderpool G E, Carroll M S, et al. Compliance differences following administration of theophylline at 6 and 12 hour intervals. Ann Allergy 1980; 44: 283
- Weinberger M, Hendeles L, Wong L, et al. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma. J Pediatr 1981; 99: 145
- Weinberger M, Hendeles L. Slow-release theophylline rationale and basis for product selection. N Engl J Med 1983; 308: 760
- Kelly H W, Murphy S. Efficacy of a 12-hour sustained release preparation in maintaining therapeutic serum theophylline levels in asthmatic children. Pediatrics 1980; 66: 97
- Menendez R, Kelly W, Howick J, McWilliams B C. Sustained-release theophylline. Am J Dis Child 1983; 137: 469
- American Thoracic Society: Chronic bronchitis, asthma and pulmonary emphysema. Am Rev Re-spir Dis 1962; 85: 762
- Wagner J G. Method of estimating relative absorption of a drug in a series of clinical studies in which blood levels are measured after single and/ or multiple doses. J Pharmacol Sci 1976; 56: 652
- Ellis E S, Koysooko R, Levy G. Pharmacokinetics of theophylline in children with asthma. Pediatrics 1976; 58: 542
- Menendez R, Kelly H W. Theophylline therapy. J Asthma 1983; 20: 455